mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
7e-05 |
mRNA |
BX-912 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
7e-05 |
mRNA |
PF-562271 |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
7e-05 |
mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
9e-05 |
mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0001 |
mRNA |
Cerulenin |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
mRNA |
Bexarotene |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
0.0001 |
mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |
mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0001 |